This page shows the latest Aragon Pharma news and features for those working in and with pharma, biotech and healthcare.
J&J acquired Erleada when it took over Aragon Pharma in 2013 in a deal valued at $1bn.
The deal secures a promising new prostate cancer therapy for the pharma major in the form of Aragon's ARN-509, a second generation androgen receptor signalling inhibitor which has reached ... Seragon spun out. The closure of the deal also sees the
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...